Ftse Mib
39.224,71
1,32%
DAX
22.794,11
1,78%
S&P 500
5.956,06
0,01%
NASDAQ
19.075,26
0,26%
Bitcoin
84.239,50
0,19%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Trevi Therapeutics Inc (TRVI) Trevi Therapeutics Inc (TRVI) Notizie

Trevi Therapeutics Inc

TRVI
4,51
-0,01 (-0,22%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:03:24
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/2/202513:30PRNUSTrevi Therapeutics Completes Enrollment for Phase 2b CORAL..
21/2/202513:30BWFNB Harvest annonce les distributions de février 2025
20/2/202522:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202522:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202500:04EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
14/2/202517:21EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
13/2/202522:01EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
13/2/202519:41EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
30/1/202513:30PRNUSTrevi Therapeutics to Participate in Upcoming February..
24/1/202513:30BWFNB Harvest annonce les distributions de janvier 2025
10/1/202522:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202514:00EDGAR2Form 8-K - Current report
08/1/202513:30PRNUSTrevi Therapeutics Announces Company Updates Ahead of 14th..
31/12/202421:03BWFNB Harvest annonce les distributions annuelles finales..
23/12/202420:24BWFNB Harvest annonce Distributions réinvesties annuelles..
20/12/202413:30BWFNB Harvest annonce les distributions de décembre 2024
16/12/202423:20EDGAR2Form 8-K - Current report
16/12/202423:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/12/202413:36PRNUSTrevi Therapeutics Announces Pricing of $50 Million..
12/12/202414:00EDGAR2Form 8-K - Current report
12/12/202413:30PRNUSTrevi Therapeutics Announces Positive Outcome from Sample..
03/12/202423:20EDGAR2Form 8-K - Current report
03/12/202422:05PRNUSTrevi Therapeutics Announces Positive Topline Results from..
28/11/202423:24BWFNB Harvest annonce Distributions réinvesties annuelles..
22/11/202413:30BWFNB Harvest annonce les distributions de novembre 2024
21/11/202413:30PRNUSTrevi Therapeutics to Participate in Piper Sandler 36th..
14/11/202423:51EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
09/11/202400:57EDGAR2Form SC 13D/A - General Statement of Acquisition of..
06/11/202422:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202422:12EDGAR2Form 8-K - Current report
06/11/202422:05PRNUSTrevi Therapeutics Reports Third Quarter 2024 Financial..
06/11/202416:30EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
30/10/202421:05PRNUSTrevi Therapeutics to Report Third Quarter 2024 Financial..
24/10/202413:30BWFNB Harvest annonce les distributions d’octobre 2024
23/10/202420:44EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
21/10/202416:43EDGAR2Form 8-K - Current report
21/10/202413:30PRNUSTrevi Therapeutics Completes Enrollment for Phase 2a RIVER..
15/10/202413:30PRNUSTrevi Therapeutics to Participate in Upcoming Commercial and..
04/10/202414:07EDGAR2Form 8-K - Current report
03/10/202422:05PRNUSTrevi Therapeutics Provides Update on Haduvio's Clinical..
30/9/202423:30PRNUSTrevi Therapeutics Announces Appointment of James V...
26/9/202413:30PRNUSTrevi Therapeutics Announces Additional Analyses of Cough..
23/9/202413:30BWFNB Harvest annonce les distributions de septembre 2024
04/9/202422:05PRNUSTrevi Therapeutics Announces Oral Presentation on Data from..
28/8/202413:30PRNUSTrevi Therapeutics to Participate in September Investor and..
23/8/202413:30BWFNB Harvest annonce les distributions d’août 2024
08/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:09EDGAR2Form 8-K - Current report
08/8/202422:05PRNUSTrevi Therapeutics Reports Second Quarter 2024 Financial..
01/8/202413:30PRNUSTrevi Therapeutics to Report Second Quarter 2024 Financial..
Apertura: 4,41 Min: 4,41 Max: 4,71
Chiusura: 4,52

La tua Cronologia

NASDAQ
TRVI
Trevi Therapeutics
BOV
P2BH34
Prestige Consumer Health...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci